跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,385 条关于
“Otsuka Holding Co.”
全部
14,385
临床试验
4,110
药物
1,084
机构
1,795
资讯
7,396
10个月前
Taiho Pharmaceutical Challenges USPTO Over $1 Billion LYTGOBI Patent Extension Denial
去年
Cantargia Advances Nadunolimab Development Following TRIFOUR Trial Results, Secures Otsuka Partnership for CAN10 Program
9个月前
Australian Court Rules Formulation Patents Ineligible for Patent Term Extensions in Landmark Otsuka Decision
去年
Otsuka Seeks Approval in Japan for Bempedoic Acid to Treat Hypercholesterolemia
12个月前
Otsuka Receives Japanese Approval for NEXLETOL as Novel Non-Statin Cholesterol Treatment
去年
KEYNOTE-057 Trial Explores Vibostolimab and Favezelimab Combinations with Pembrolizumab in BCG-Unresponsive NMIBC
9个月前
Otsuka Submits FDA Application for First-in-Class ADHD Drug Centanafadine
6个月前
Otsuka's Paradise Ultrasound Renal Denervation System Gains Insurance Coverage in Japan for Resistant Hypertension
去年
Otsuka Pharmaceutical Acquires Cantargia's CAN10 Antibody Program for $33 Million Upfront in Autoimmune Disease Deal
去年
Otsuka Pharmaceutical Secures Global Rights to HBM7020 BCMAxCD3 Bispecific T-Cell Engager for Autoimmune Diseases
第 1 页,共 740 页
上一页
下一页